Royalty Pharma Reports Third Quarter 2024 Results

Go back to Royalty Pharma Reports Third Quarter 2024 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 60.88 -0.85 (1.38%)
Previous Close $61.73    52 Week High $3.48 
Open $61.33    52 Week Low $0.80 
Day High $62.13    P/E N/A 
Day Low $60.80    EPS $-1.54 
Volume 1,474,062